COMMUNIQUÉS West-GlobeNewswire

Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients

20/06/2017 - 07:00

PRESS RELEASE Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients Pfäffikon, SZ, June 20, 2017, and Leuven, [...]

Takeda et TiGenix annoncent que Swissmedic a accepté la demande d'évaluation relative au Cx106 pour le traitement des fistules périanales complexes chez les patients atteints de la maladie de Crohn.

20/06/2017 - 07:00

COMMUNIQUÉ DE PRESSE Takeda et TiGenix annoncent que Swissmedic a accepté la demande d'évaluation relative au Cx106 pour le traitement des fistules périanales complexes chez les patients atteints de la maladie de Crohn [...]

Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma

20/06/2017 - 02:01

Press Release 20 June 2017 Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma Immunicum AB (publ; First [...]

Sanofi : Disclosure of trading in own shares

19/06/2017 - 19:15

Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Sanofi : Déclaration des transactions sur actions propres

19/06/2017 - 19:15

Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Ossur Hf : Transactions in relation to share buyback program

19/06/2017 - 18:00

Announcement from Össur hf. No. 45/2017 Reykjavík, 19 June 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017

19/06/2017 - 15:30

PRESS RELEASE Lund - Active Biotech AB (Nasdaq Stockholm: ACTI) today announces that the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB. Helén Tuvesson will take up the [...]

Novo Nordisk A/S - Share repurchase programme

19/06/2017 - 14:48

Bagsværd, Denmark, 19 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Extrodinary General Shareholders' Meeting

19/06/2017 - 14:30

NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM - 14:30 CEST, June 19 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda [...]

Assemblée Générale Extraordinaire des Actionnaires

19/06/2017 - 14:30

COMMUNIQUE DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE, le 19 juin , 14:30 CEST - MDxHealth SA (Euronext: MDXH.BR) a tenu aujourd'hui son Assemblée Générale Extraordinaire des Actionnaires à Bruxelles. Les actionnaires [...]

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

19/06/2017 - 13:57

Seneffe, June 19, 2017. The Minutes and all relevant documents regarding the Annual General Meeting 2017 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert & [...]

Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale des actionnaires

19/06/2017 - 13:57

Seneffe, le 19 juin 2017. Le procès verbal ainsi que tous les documents relatifs à l'Assemblé Générale 2017 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/shareholder_information/ A [...]

Glepaglutide meets primary endpoint in Phase 2 trial in patients with short bowel syndrome

19/06/2017 - 09:59

Glepaglutide* is a novel long-acting GLP-2 analogue Reduction in fecal wet weight output of 30% and 23% in the two highest dose groups Increases in gastrointestinal fluid and energy absorption observed The dose response [...]

187,133 Orion Corporation A shares converted into B shares

19/06/2017 - 09:50

ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2017 at 10.50 a.m. EEST 187,133 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 187, [...]

Diaxonhit : Nouvelle composition du conseil de surveillance

19/06/2017 - 07:30

Nouvelle composition du conseil de surveillance de DIAXONHIT Jean-Pierre HERMET est nommé président du conseil de surveillance Patrick de ROQUEMAUREL est nommé membre du conseil de surveillance Démissions de Laurent [...]

Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases

19/06/2017 - 07:15

European Commission approves Sandoz Rixathon ® to treat blood cancers and immunological diseases. Approval expected to broa den patient access to biologics and enable budget-constrained healthcare systems to reallocate [...]

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

19/06/2017 - 07:00

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 19, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with [...]

MDxHealth et l'Université de technologie du Queensland collaborent sur un test de biopsie liquide pour le dépistage de cancer buccal

19/06/2017 - 07:00

COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 19 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui qu'il a signé un [...]

Medtronic Exclusive Reactive ATP(TM) Therapy Slows Progression of Atrial Fibrillation in Real-World Patient Population

18/06/2017 - 15:00

Data Presented as Late Breaking Clinical Trial at EUROPACE 2017 DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: [...]